The Cooper Companies, Inc.(COO)

NASDAQ Global Select
Sector: Healthcare | Industry: Medical - Instruments & Supplies
The Cooper Companies, Inc. logo

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Latest News & Analysis

Cooper Companies (COO) Q1 2025 Earnings Analysis: Revenue Miss Impacts Stock, Investors Concerned.
Mar 10, 2025

Cooper Companies (COO) Q1 2025 Earnings: Revenue Miss Signals Challenges Ahead?

Cooper Companies' Q1 2025 earnings revealed a revenue miss despite matching EPS estimates. CooperVision's growth contrasts with CooperSurgical's challenges.

Read more →
CooperCompanies Q1 2025 Earnings Preview: Analysis of COO stock, market trends, and strategic acquisitions impacting the medical device company's performance. Key metrics, analyst outlook, and risk assessment.
Feb 28, 2025

CooperCompanies (COO) Q1 2025 Earnings Preview: Market Trends and Analysis

CooperCompanies (COO) prepares for Q1 2025 earnings amid market shifts. This analysis covers segments, acquisitions, trends, and expectations, offering key insights for investors.

Read more →
CooperCompanies (COO) Q1 2025 Earnings Preview: Vision Care & Women's Health Growth Analysis
Feb 27, 2025

CooperCompanies (COO) Q1 2025 Earnings Preview: Navigating Growth in Vision Care & Women's Health

CooperCompanies (COO) Q1 2025 earnings preview: Navigating mixed market signals, strategic acquisitions, and international expansion. Key insights for investors.

Read more →
CooperCompanies Q1 2025 Earnings Preview: Analysis of acquisition impact, market trends, CooperVision performance, and CooperSurgical growth strategies. Stay informed on COO's financial outlook.
Feb 25, 2025

CooperCompanies (COO) Q1 2025 Earnings Preview: Acquisition Impact

A comprehensive analysis of CooperCompanies' Q1 2025 earnings preview, acquisition impacts, and strategic market positioning. Key insights for investors and analysts.

Read more →
CooperCompanies Q1 2025 Earnings Preview: Market analysis of COO, including CooperVision and CooperSurgical performance, financial health, and growth prospects. Stay informed on analyst expectations and strategic initiatives.
Feb 24, 2025

CooperCompanies (COO): Q1 2025 Earnings Preview and Analysis

Comprehensive analysis of The Cooper Companies (COO) ahead of Q1 2025 earnings, examining market trends, financial health, and strategic initiatives.

Read more →
CooperCompanies stock performance and strategic outlook: Analysis of COO financials, revenue, and market trends. #COO #CooperCompanies #StockAnalysis
Feb 21, 2025

CooperCompanies: Strategic Outlook and Market Analysis

CooperCompanies (COO) gears up for Q1 2025 earnings amid strategic growth and market shifts. Revenue focus sharpens as acquisitions and global trends steer outlook.

Read more →
CooperCompanies (COO) 2025 Outlook: Analysis of Earnings, Market Position, and Growth Strategy in the Medical Device Industry.
Feb 21, 2025

CooperCompanies (COO): Q1 2025 Earnings Preview and Market Outlook

CooperCompanies (COO) navigates the medical device landscape amidst Q1 2025 earnings preview and strategic market positioning. Stay informed with data-driven insights.

Read more →
CooperCompanies (COO) stock analysis and market performance insights for investors and analysts, including Q4 2024 results and 2025 outlook.
Feb 21, 2025

CooperCompanies (COO): Q1 2025 Outlook and Market Analysis

CooperCompanies faces mixed market signals amid acquisition rumors and competitive pressures. Q1 2025 outlook and strategic shifts analyzed.

Read more →
CooperCompanies stock analysis: Financial performance, market trends, and future outlook for COO on February 20, 2025.
Feb 20, 2025

CooperCompanies: Analyzing Financial Performance and Future Growth in 2025

CooperCompanies' recent performance analyzed: earnings, international revenue, acquisitions, and industry trends shaping its 2025 outlook.

Read more →
Contact lenses and medical vial in a professional office setting, representing vision care and medical innovation.
Feb 18, 2025

CooperCompanies (COO): Financial Growth & Strategy in 2025

A comprehensive intraday analysis of CooperCompanies' financial performance, strategic acquisitions, and market trends driving growth in 2025.

Read more →